RxDoctor Payments Data

Adriana Garcia Aybar

Optometrist · Boca Raton, FLNPI 1700520608

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,239 of the $4,363 with a category attached, or 74.2%. 11 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 48.4% of the total. Reporting peaked in 2024 at $2,562 and has fallen 51.3% since, to $1,249 in 2025.

$4,363in general payments, 2019–2025

Across 51 payments — averaging $85.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$2K
  • Johnson & Johnson Vision Care, Inc.$1K
  • Alcon$169
  • Coopervision Inc.$163
  • Glaukos Corporation$149
  • Sight Sciences, Inc.$135
  • plus $401 from 5 others

What the payments were for

  • Travel & lodging$1,12526%
  • Food & beverage$3,23974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,363 in reported general payments places this provider in the 85th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida →

Medicare billing

Part B allowed, 2024
$161,805
Medicare patients
766
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost22$561

Paid to pharmacies, not to this prescriber.

Other optometrist in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →